CN Stock MarketDetailed Quotes

000623 Jilin Aodong Pharmaceutical Group

Watchlist
  • 15.06
  • -0.02-0.13%
Trading Apr 29 09:39 CST
18.01BMarket Cap12.33P/E (TTM)

Jilin Aodong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jilin Aodong Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

1.10B

+14.64%
Net Income(YoY)

174.32M

-80.93%
Analyst Rating

Strong Buy

Apr 28, 2024

Jilin Aodong Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.831B--
--2024/FY-- / 4.121B--
--2023/FY3.449B / 3.450B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.831B--
--2024/FY-- / 4.121B--
--2023/FY3.449B / 3.450B--

Jilin Aodong Pharmaceutical Group Earnings Reports

  • Aodong, Jilin: 2023 Annual Report Summary

    Apr 17 00:00

  • Aodong, Jilin: Annual Report 2023

    Apr 17 00:00

  • Aodong, Jilin: Report for the third quarter of 2023

    Oct 31, 2023 00:00

  • Aodong, Jilin: Summary of the 2023 Semi-Annual Report

    Aug 31, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg